Bryan Deane
New Medicines & Data Policy Director, Association of the British Pharmaceutical Industry (ABPI)


After graduating in Pharmacology and completing a PhD in Neuropathology, a variety of positions at SmithKline Beecham and GlaxoSmithKline were mostly focussed on commercial development, including regional input to early valuation of potential new medicines and to the design of the clinical development programmes to deliver them. These covered a variety of therapy areas including infectious diseases, respiratory diseases, gastroenterology, diabetes and oncology and experience of a wide range of countries and regions, from the UK to China and from Latin America to Asia-Pacific. This included a major role directing the implementation of a China joint-venture on a green field site, covering partner negotiation, factory build, and clinical development and registration. A period as a freelance consultant followed, leading a variety of projects such as new product launches, medical affairs programmes and restructuring healthcare agencies, as well as a joint project with the ABPI exploring clinical trial transparency. Bryan joined the ABPI’s Research, Medical & Innovation Team in May 2018, covering all aspects of New Medicines Development, including specific responsibility for Advanced Therapy Medicinal Products, Antimicrobial Resistance, and the Medicines Manufacturing Industry Partnership.
Processing. Please wait.